ClinicalTrials.govpublic full text
Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction
acromegaly, somatostatin analogues, lanreotide, octreotide, gh, igf-i, injection site, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 904945
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.